Breast cancer statistics 2024
This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high‐quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by...
Gespeichert in:
| Veröffentlicht in: | CA: a cancer journal for clinicians Jg. 74; H. 6; S. 477 - 495 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Wiley Subscription Services, Inc
01.11.2024
|
| Schlagworte: | |
| ISSN: | 0007-9235, 1542-4863, 1542-4863 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high‐quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012–2021, largely confined to localized‐stage and hormone receptor‐positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989–2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black‐White disparity partly reflects more triple‐negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high‐quality screening and treatment. |
|---|---|
| AbstractList | This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012-2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989-2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black-White disparity partly reflects more triple-negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high-quality screening and treatment. This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012-2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989-2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black-White disparity partly reflects more triple-negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high-quality screening and treatment.This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012-2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989-2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black-White disparity partly reflects more triple-negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high-quality screening and treatment. This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012–2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989–2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black-White disparity partly reflects more triple-negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high-quality screening and treatment. |
| Author | Giaquinto, Angela N. Jemal, Ahmedin Freedman, Rachel A. Newman, Lisa A. Star, Jessica Siegel, Rebecca L. Sung, Hyuna Smith, Robert A. |
| Author_xml | – sequence: 1 givenname: Angela N. orcidid: 0000-0003-2548-9693 surname: Giaquinto fullname: Giaquinto, Angela N. email: angela.giaquinto@cancer.org organization: American Cancer Society – sequence: 2 givenname: Hyuna orcidid: 0000-0002-8021-5997 surname: Sung fullname: Sung, Hyuna organization: American Cancer Society – sequence: 3 givenname: Lisa A. orcidid: 0000-0003-2059-0477 surname: Newman fullname: Newman, Lisa A. organization: Weill Cornell Medicine – sequence: 4 givenname: Rachel A. orcidid: 0000-0003-0460-674X surname: Freedman fullname: Freedman, Rachel A. organization: Harvard Medical School – sequence: 5 givenname: Robert A. surname: Smith fullname: Smith, Robert A. organization: American Cancer Society – sequence: 6 givenname: Jessica orcidid: 0000-0003-3522-9609 surname: Star fullname: Star, Jessica organization: American Cancer Society – sequence: 7 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin organization: American Cancer Society – sequence: 8 givenname: Rebecca L. orcidid: 0000-0001-5247-8522 surname: Siegel fullname: Siegel, Rebecca L. organization: American Cancer Society |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39352042$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90M1LwzAYBvAgivvQi3dl4EWEzjdfTXOcxS8YeNFzSLMEOrp2Ji2y_97UTg9DPCWB3_OS95mg47qpLUIXGOaUEnJntDZzgrOUHqEx5owkLN6P0RgARCIJ5SM0CWEN_VuIUzSiknICjIzR5b23OrQzo2tj_Sy0ui1DW5owI0DYGTpxugr2fH9O0fvjw1v-nCxfn17yxTIxjEuaMMCauCwVwLRgDlLAKS0EOMOFLBimTgIXRlqSiVUU3DhOCsFXhOlMgqZTdDPM3frmo7OhVZsyGFtVurZNFxTFOE4UTGaRXh_QddP5Ov4uKgqZ4GmaRnW1V12xsSu19eVG-536WTyC2wEY34TgrfslGFTfqupbVd-tRgwH2JR9UU3del1Wf0fwEPksK7v7Z7jKF4t8yHwBRxyEAA |
| CitedBy_id | crossref_primary_10_1161_JAHA_125_044046 crossref_primary_10_1007_s12672_025_02546_8 crossref_primary_10_1016_j_ctrv_2025_102924 crossref_primary_10_3389_fphar_2025_1627883 crossref_primary_10_1016_j_phymed_2024_156226 crossref_primary_10_1002_advs_202507126 crossref_primary_10_1016_j_tranon_2025_102420 crossref_primary_10_1177_1934578X251344985 crossref_primary_10_1371_journal_pone_0326224 crossref_primary_10_1016_j_talanta_2025_128411 crossref_primary_10_3389_fimmu_2025_1626411 crossref_primary_10_1007_s12609_025_00595_0 crossref_primary_10_3389_fonc_2025_1535421 crossref_primary_10_1016_j_bmcl_2025_130112 crossref_primary_10_1016_j_poly_2025_117560 crossref_primary_10_1016_j_prp_2025_155866 crossref_primary_10_1177_17588359251337493 crossref_primary_10_3390_ijms26010376 crossref_primary_10_1007_s11845_025_04011_5 crossref_primary_10_1093_oncolo_oyaf101 crossref_primary_10_1200_GO_25_00139 crossref_primary_10_31083_CEOG37161 crossref_primary_10_1016_j_canlet_2025_217865 crossref_primary_10_1200_EDBK_25_471924 crossref_primary_10_1177_03000605251325961 crossref_primary_10_1007_s10528_025_11051_0 crossref_primary_10_1080_14796694_2025_2485022 crossref_primary_10_3390_biomedicines13051089 crossref_primary_10_3390_ijms26136038 crossref_primary_10_3390_biomedicines13040990 crossref_primary_10_2147_BCTT_S516125 crossref_primary_10_1200_JCO_25_00812 crossref_primary_10_7759_cureus_82762 crossref_primary_10_1007_s12672_025_02752_4 crossref_primary_10_1002_adfm_202508310 crossref_primary_10_1002_cncy_70026 crossref_primary_10_1016_j_ejso_2025_109627 crossref_primary_10_1155_ecc_8849747 crossref_primary_10_1016_j_ejon_2025_102825 crossref_primary_10_5812_jjnpp_160754 crossref_primary_10_1021_acs_biomac_5c01439 crossref_primary_10_4040_jkan_25011 crossref_primary_10_1002_adfm_202504621 crossref_primary_10_1007_s10549_024_07594_2 crossref_primary_10_3390_biom15071048 crossref_primary_10_1007_s12668_025_02149_1 crossref_primary_10_1096_fj_202500158R crossref_primary_10_3389_fonc_2025_1536779 crossref_primary_10_1080_14796694_2024_2447813 crossref_primary_10_1007_s12672_025_03379_1 crossref_primary_10_1007_s12672_025_02702_0 crossref_primary_10_1021_acs_jproteome_5c00170 crossref_primary_10_1002_mco2_70243 crossref_primary_10_1016_j_phymed_2025_156611 crossref_primary_10_1186_s12912_025_02977_2 crossref_primary_10_1186_s40959_024_00298_y crossref_primary_10_1038_s41598_025_10176_x crossref_primary_10_1136_jitc_2024_010924 crossref_primary_10_1007_s13187_025_02667_2 crossref_primary_10_1016_j_ejca_2024_115166 crossref_primary_10_1177_00368504251362350 crossref_primary_10_1002_jmri_29736 crossref_primary_10_1002_slct_202404806 crossref_primary_10_32635_2176_9745_RBC_2025v71n3_5089 crossref_primary_10_1007_s11831_025_10372_y crossref_primary_10_1016_j_ijrobp_2025_04_031 crossref_primary_10_1007_s11912_025_01711_0 crossref_primary_10_1093_jbi_wbaf031 crossref_primary_10_1109_ACCESS_2025_3594827 crossref_primary_10_3389_fmolb_2025_1580622 crossref_primary_10_1186_s41065_025_00425_4 crossref_primary_10_1186_s12885_025_13975_7 crossref_primary_10_1016_j_molstruc_2025_142278 crossref_primary_10_1007_s12672_025_02736_4 crossref_primary_10_3390_vaccines13040337 crossref_primary_10_3322_caac_70011 crossref_primary_10_1002_slct_202404148 crossref_primary_10_1007_s10552_025_02043_x crossref_primary_10_1007_s12687_025_00806_2 crossref_primary_10_1021_acsnano_5c08767 crossref_primary_10_1186_s43556_025_00306_2 crossref_primary_10_1007_s44411_025_00237_y crossref_primary_10_62347_DYFF7059 crossref_primary_10_1016_S1773_035X_24_00374_5 crossref_primary_10_1080_17568919_2025_2515816 crossref_primary_10_3892_ol_2025_15158 crossref_primary_10_1007_s00210_025_04003_3 crossref_primary_10_1016_j_semperi_2025_152037 crossref_primary_10_1021_acsanm_5c03343 crossref_primary_10_3390_ijms26062795 crossref_primary_10_3390_jfb16060220 crossref_primary_10_1016_j_mtnano_2025_100647 crossref_primary_10_1021_acsami_5c05585 crossref_primary_10_3389_fonc_2025_1554888 crossref_primary_10_55905_cuadv17n7_071 crossref_primary_10_7759_cureus_80795 crossref_primary_10_1002_jum_16664 crossref_primary_10_1007_s12010_025_05233_0 crossref_primary_10_3390_v17030324 crossref_primary_10_1080_17568919_2025_2498881 crossref_primary_10_1136_bmj_q2199 crossref_primary_10_1158_1055_9965_EPI_24_1646 crossref_primary_10_1186_s12957_025_03874_3 crossref_primary_10_3390_ijms26062661 crossref_primary_10_1016_j_mtbio_2025_101784 crossref_primary_10_3389_fimmu_2025_1658571 crossref_primary_10_1158_2767_9764_CRC_25_0023 crossref_primary_10_2147_JIR_S518232 crossref_primary_10_3389_fonc_2025_1478701 crossref_primary_10_1007_s40487_025_00337_3 crossref_primary_10_3390_bioengineering12020146 crossref_primary_10_1007_s12668_025_02046_7 crossref_primary_10_1039_D5MH00888C crossref_primary_10_1186_s13058_025_02052_3 crossref_primary_10_1097_GME_0000000000002568 crossref_primary_10_1515_oncologie_2025_0080 crossref_primary_10_2147_CEOR_S496606 crossref_primary_10_1016_j_jclinane_2025_111805 crossref_primary_10_1515_oncologie_2024_0471 crossref_primary_10_1007_s00266_025_05163_6 crossref_primary_10_1055_a_2596_8059 crossref_primary_10_21518_ms2025_205 crossref_primary_10_3390_curroncol32060305 crossref_primary_10_17714_gumusfenbil_1624557 crossref_primary_10_1007_s00520_025_09815_w crossref_primary_10_4103_YWBC_YWBC_4_25 crossref_primary_10_62347_CZYA6232 crossref_primary_10_3390_jcm14134568 crossref_primary_10_1080_14786419_2025_2511158 crossref_primary_10_1016_j_phrs_2024_107534 crossref_primary_10_3390_nu16234214 crossref_primary_10_1007_s10549_025_07734_2 crossref_primary_10_1007_s00604_025_07517_y crossref_primary_10_1109_ACCESS_2025_3575126 crossref_primary_10_1016_j_molstruc_2025_142800 crossref_primary_10_1007_s12609_025_00575_4 crossref_primary_10_1016_j_amjsurg_2024_116013 crossref_primary_10_1038_s41598_025_88765_z crossref_primary_10_1007_s00210_025_04020_2 crossref_primary_10_3389_fphar_2025_1571135 crossref_primary_10_1021_acsami_4c21725 crossref_primary_10_1186_s12889_025_22855_5 crossref_primary_10_1002_adbi_202400846 crossref_primary_10_1007_s11033_025_10739_1 crossref_primary_10_3389_fphar_2025_1547333 crossref_primary_10_1001_jamanetworkopen_2024_61353 crossref_primary_10_47026_2413_4864_2025_1_51_59 crossref_primary_10_1055_a_2531_9761 crossref_primary_10_1152_ajpheart_00323_2025 crossref_primary_10_1007_s00520_025_09647_8 crossref_primary_10_1186_s40001_025_02806_x crossref_primary_10_1007_s10549_024_07562_w crossref_primary_10_1002_advs_202501064 crossref_primary_10_1080_14737140_2025_2471010 crossref_primary_10_1021_acsabm_5c00046 crossref_primary_10_4103_bbrj_bbrj_42_25 crossref_primary_10_3389_fonc_2025_1540538 crossref_primary_10_1007_s00726_025_03456_3 crossref_primary_10_3389_fonc_2025_1561599 crossref_primary_10_3390_cancers17101652 crossref_primary_10_1111_jftr_12612 crossref_primary_10_1177_10711813251367742 crossref_primary_10_1016_j_jsbmb_2025_106745 crossref_primary_10_1007_s12609_025_00598_x crossref_primary_10_3389_fmolb_2025_1510896 crossref_primary_10_1038_s41598_025_03025_4 crossref_primary_10_1016_j_cstres_2025_03_003 crossref_primary_10_1109_ACCESS_2025_3581582 crossref_primary_10_3389_fphar_2025_1538601 crossref_primary_10_1002_bcp_70183 crossref_primary_10_1002_adfm_202512905 crossref_primary_10_5582_bst_2025_01046 crossref_primary_10_1001_jamaoncol_2024_6868 crossref_primary_10_1007_s12032_025_02836_9 crossref_primary_10_20517_cdr_2025_69 crossref_primary_10_3389_fonc_2025_1638212 crossref_primary_10_1001_jamanetworkopen_2025_16947 crossref_primary_10_1007_s10557_025_07684_3 crossref_primary_10_1111_cas_70121 crossref_primary_10_1007_s12668_025_01980_w crossref_primary_10_1007_s12609_025_00585_2 crossref_primary_10_1080_15257770_2025_2498642 crossref_primary_10_1007_s10549_025_07752_0 crossref_primary_10_3390_curroncol32060344 crossref_primary_10_3389_fonc_2025_1555921 crossref_primary_10_1093_radadv_umaf007 crossref_primary_10_7717_peerj_19694 crossref_primary_10_2147_IJN_S502144 crossref_primary_10_3390_molecules30071571 crossref_primary_10_2196_69864 crossref_primary_10_3390_jpm15050177 crossref_primary_10_1080_27697061_2024_2442631 crossref_primary_10_1007_s12282_025_01697_4 crossref_primary_10_1002_adhm_202502530 crossref_primary_10_3390_cells14110828 crossref_primary_10_3322_caac_21874 crossref_primary_10_3322_caac_21871 crossref_primary_10_1016_j_annonc_2025_01_014 crossref_primary_10_1016_j_ccell_2025_03_022 crossref_primary_10_1186_s13058_025_02059_w crossref_primary_10_62347_XAKQ8090 crossref_primary_10_3390_biomedicines13071691 crossref_primary_10_3390_ijms26031300 crossref_primary_10_3390_cancers17111781 crossref_primary_10_5306_wjco_v16_i5_104623 crossref_primary_10_3322_caac_21867 crossref_primary_10_1016_j_tranon_2025_102280 crossref_primary_10_2147_DDDT_S510222 |
| Cites_doi | 10.1093/ije/dyl089 10.1007/s11113‐021‐09647‐6 10.1093/jncimonographs/lgu016 10.1056/nejmp2200244 10.1158/1055‐9965.epi‐10‐0021 10.1093/jnci/djv159 10.1016/j.canep.2018.11.006 10.1093/jnci/djae172 10.1002/cncr.32293 10.1093/jnci/djaa148 10.1016/j.clinimag.2021.08.013 10.1136/bmj‐2022‐071674 10.1158/1538‐7445.sabcs22‐gs1‐01 10.1007/s10549‐017‐4229‐1 10.3389/fonc.2020.01301 10.1093/jnci/djaa215 10.1007/s10552‐013‐0323‐9 10.15620/cdc/151797 10.1007/s10552‐009‐9437‐5 10.1002/cncr.33527 10.1016/j.jamcollsurg.2020.01.031 10.1200/jco.23.01199 10.1200/jco.2017.73.7932 10.3389/fonc.2020.01022 10.1158/2159‐8290.cd‐22‐0138 10.1001/jamasurg.2023.8024 10.1097/sla.0000000000003459 10.1001/jamaoncol.2021.1254 10.3322/caac.21757 10.3390/ijerph182211824 10.1200/jop.2017.023333 10.1002/ijc.31258 10.1093/jnci/djv048 10.5888/pcd16.180221 10.1001/jamaoncol.2017.0595 10.1093/jnci/djab186 10.3322/caac.21820 10.1158/1055‐9965.epi‐20‐1055 10.1002/cncr.34241 10.3322/ca.2007.0011 10.1056/nejmsr070105 10.1002/cncr.34015 10.1093/jncics/pkac016 10.1158/1055‐9965.epi‐17‐0945 10.1001/jama.2024.5535 10.1158/1055‐9965.epi‐18‐0098 10.3322/caac.21732 10.1093/jnci/djad033 10.1093/jnci/djad086 10.1002/cam4.4158 10.1007/s10549‐019‐05403‐9 10.1093/jnci/djr257 10.1158/0008‐5472.can‐18‐0502 10.1001/jamanetworkopen.2020.37546 10.1007/s10549‐020‐05545‐1 10.1097/00008469‐199311000‐00001 10.1001/jamanetworkopen.2023.44517 10.1001/jamaoncol.2022.0159 10.1001/jamaoncol.2022.2617 10.1001/jamaoncol.2015.3856 10.1093/jnci/djm026 10.1158/1055‐9965.epi‐20‐0924 10.1016/s0140‐6736(17)30569‐x 10.1097/sla.0000000000006177 10.1007/s10549‐005‐9101‐z 10.1093/jnci/djac172 10.1158/1055‐9965.epi‐16‐0721 10.1097/mlr.0000000000000417 10.3322/caac.21388 10.1093/jnci/djac158 10.1002/cam4.5808 10.1001/jama.2015.12783 10.1200/jco.22.02170 10.1001/jama.2023.25881 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. Copyright Wiley Subscription Services, Inc. Nov/Dec 2024 |
| Copyright_xml | – notice: 2024 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. – notice: Copyright Wiley Subscription Services, Inc. Nov/Dec 2024 |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 8FD FR3 H94 K9. NAPCQ P64 RC3 7X8 |
| DOI | 10.3322/caac.21863 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Nursing & Allied Health Premium CrossRef |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1542-4863 |
| EndPage | 495 |
| ExternalDocumentID | 39352042 10_3322_caac_21863 CAAC21863 |
| Genre | article Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | .GA .GJ .Y3 0R~ 10A 18M 1CY 1OB 1OC 23N 24P 2WC 31~ 33P 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52P 52R 52S 52T 52X 53G 5GY 5RE 5VS 66C 6J9 6PF 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAONW AAWTL AAZKR ABCQN ABEML ACBNA ACCFJ ACCMX ACGFO ACPRK ACSCC ACXQS ADBBV ADIZJ ADPDF ADXAS ADZOD AEEZP AEGXH AEIMD AEQDE AEUQT AFBPY AFFNX AFZJQ AHMBA AI. AIAGR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ATUGU AZBYB BAFTC BAWUL BFHJK BKOMP BY8 C1A CS3 D-6 D-7 D-E D-F DCZOG DIK DR2 E3Z EBD EBS EIHBH EJD EMB EMOBN F00 F01 F04 F5P FAS FJW G-S GODZA GX1 H.X HZ~ IX1 J0M KQ8 L7B LC2 LC3 LH4 LW6 N04 N05 NF~ O66 O9- OHT OK1 OVD P2P P2W P2X P2Z P4E PQQKQ Q.N Q11 QB0 ROL RWI RWL RX1 RXW SJN SUPJJ SV3 TAE TEORI TR2 TWZ UB1 UDS VH1 W2D W8V WH7 WHWMO WIN WOHZO WOQ WQJ WRC WVDHM WXI XG1 XSB XV2 XZL YQJ ZCG ZGI ZVN ZXP ~WT AAFWJ AAYXX CITATION O8X OVT CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 8FD FR3 H94 K9. NAPCQ P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c4593-401a2f86704a74f060163b70fc579b413f9057c9e287da745cf52b75d24a890a3 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 375 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001322701200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-9235 1542-4863 |
| IngestDate | Wed Oct 01 14:36:57 EDT 2025 Thu Oct 02 22:11:52 EDT 2025 Mon Jul 21 06:00:31 EDT 2025 Sat Nov 29 06:53:51 EST 2025 Tue Nov 18 22:08:50 EST 2025 Wed Jan 22 17:15:12 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | epidemiology health disparities breast neoplasms molecular subtype mortality breast cancer incidence |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2024 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4593-401a2f86704a74f060163b70fc579b413f9057c9e287da745cf52b75d24a890a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5247-8522 0000-0003-2548-9693 0000-0002-8021-5997 0000-0003-0460-674X 0000-0003-3522-9609 0000-0003-2059-0477 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21863 |
| PMID | 39352042 |
| PQID | 3130875666 |
| PQPubID | 6515 |
| PageCount | 19 |
| ParticipantIDs | proquest_miscellaneous_3111637498 proquest_journals_3130875666 pubmed_primary_39352042 crossref_primary_10_3322_caac_21863 crossref_citationtrail_10_3322_caac_21863 wiley_primary_10_3322_caac_21863_CAAC21863 |
| PublicationCentury | 2000 |
| PublicationDate | November/December 2024 |
| PublicationDateYYYYMMDD | 2024-11-01 |
| PublicationDate_xml | – month: 11 year: 2024 text: November/December 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta |
| PublicationTitle | CA: a cancer journal for clinicians |
| PublicationTitleAlternate | CA Cancer J Clin |
| PublicationYear | 2024 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2023; 73 2017; 3 2010; 19 2006; 35 2022; 72 2023; 6 2023; 381 2021; 127 2019; 58 2019; 16 2024; 74 2014; 25 2019; 125 2024 2015; 107 2020; 10 2021; 30 1993; 2 2023; 83 2021; 70 2010; 21 2021; 113 2024; 159 2019; 28 2017; 164 2018; 78 2022; 128 2019; 270 2021; 40 2018; 36 2021; 80 2018; 142 2021; 7 2006; 97 2021; 4 2023; 280 2023; 12 2012 2017; 26 2020; 180 2015; 53 2017; 67 2008; 58 2014; 2014 2007; 99 2023–2024 2018; 27 2022; 114 2007; 356 2022; 386 2011; 103 2023; 41 2021; 10 2016; 2 2023 2015; 314 2022 2020 2022; 6 2020; 230 2021; 18 2022; 8 2017; 13 2022; 12 2023; 115 2024; 42 2024; 331 2017; 389 2019; 178 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_83_1 e_1_2_7_62_1 e_1_2_7_81_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_87_1 e_1_2_7_43_1 e_1_2_7_66_1 Keisler‐Starkey K (e_1_2_7_75_1) 2023 e_1_2_7_85_1 e_1_2_7_11_1 Statistical Research and Applications Branch, National Cancer Institute (NCI) (e_1_2_7_18_1) 2012 American Cancer Society (e_1_2_7_52_1) 2023 e_1_2_7_68_1 e_1_2_7_47_1 e_1_2_7_89_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_90_1 Centers for Disease Control and Prevention (e_1_2_7_14_1) 2023 e_1_2_7_73_1 e_1_2_7_94_1 e_1_2_7_50_1 e_1_2_7_71_1 e_1_2_7_92_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_77_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_96_1 e_1_2_7_21_1 e_1_2_7_35_1 American Cancer Society (e_1_2_7_45_1) 2024 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_58_1 e_1_2_7_79_1 e_1_2_7_39_1 Surveillance Research Program, National Cancer Institute (NCI) (e_1_2_7_16_1) 2024 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_80_1 e_1_2_7_8_1 e_1_2_7_84_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_82_1 e_1_2_7_2_1 e_1_2_7_42_1 e_1_2_7_63_1 e_1_2_7_88_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 e_1_2_7_86_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_67_1 e_1_2_7_48_1 e_1_2_7_69_1 e_1_2_7_27_1 e_1_2_7_29_1 Arias E (e_1_2_7_20_1) 2021; 70 e_1_2_7_91_1 e_1_2_7_72_1 e_1_2_7_95_1 e_1_2_7_51_1 e_1_2_7_70_1 e_1_2_7_93_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_76_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_74_1 National Center for Health Statistics (e_1_2_7_13_1) 2022 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 Surveillance Research Program, National Cancer Institute (NCI) (e_1_2_7_17_1) 2024 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_78_1 e_1_2_7_38_1 |
| References_xml | – volume: 8 start-page: 1287 issue: 9 year: 2022 end-page: 1293 article-title: Global association of COVID‐19 pandemic measures with cancer screening: a systematic review and meta‐analysis publication-title: JAMA Oncol – volume: 107 issue: 9 year: 2015 article-title: Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States publication-title: J Natl Cancer Inst – volume: 6 issue: 2 year: 2022 article-title: Breast cancer incidence, hormone receptor status, historical redlining, and current neighborhood Characteristics in Massachusetts, 2005–2015 publication-title: JNCI Cancer Spectr – volume: 42 start-page: 1635 issue: 14 year: 2024 end-page: 1645 article-title: Racial/ethnic disparities in pathologic complete response and overall survival in patients with triple‐negative breast cancer treated with neoadjuvant chemotherapy publication-title: J Clin Oncol – volume: 18 issue: 22 year: 2021 article-title: Association between neighborhood social deprivation and stage at diagnosis among breast cancer patients in South Carolina publication-title: Int J Environ Res Public Health – volume: 83 start-page: GS1‐01 issue: 5 suppl year: 2023 article-title: Abstract GS1‐01: Race and clinical outcomes in the RxPONDER trial (SWOG S1007) publication-title: Cancer Res – volume: 40 start-page: 895 issue: 5 year: 2021 end-page: 929 article-title: The immigrant health advantage: an examination of African‐Origin Black immigrants in the United States publication-title: Popul Res Policy Rev – volume: 114 start-page: 263 year: 2022 end-page: 270 article-title: Decreasing incidence of estrogen receptor‐negative breast cancer in the United States: trends by race and region publication-title: J Natl Cancer Inst – volume: 107 issue: 6 year: 2015 article-title: Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state publication-title: J Natl Cancer Inst – year: 2024 – year: 2023–2024 – volume: 113 start-page: 1036 issue: 8 year: 2021 end-page: 1043 article-title: Breast tumor microenvironment in Black women: a distinct signature of CD8+ T‐cell exhaustion publication-title: J Natl Cancer Inst – volume: 80 start-page: 430 year: 2021 end-page: 437 article-title: Screening mammography mitigates breast cancer disparities through early detection of triple negative breast cancer publication-title: Clin Imaging – volume: 13 start-page: 301 issue: 5 year: 2017 end-page: 303 article-title: Triple‐negative breast cancer: current practice and future directions publication-title: J Oncol Pract – volume: 2 start-page: 423 issue: 6 year: 1993 end-page: 440 article-title: Emerging worldwide trends of breast cancer incidence in the 1970s and 1980s: data from 23 cancer registration centres publication-title: Eur J Cancer Prev – volume: 7 start-page: 1016 year: 2021 end-page: 1023 article-title: Evaluation of racial/ethnic differences in treatment and mortality among women with triple‐negative breast cancer publication-title: JAMA Oncol – volume: 3 start-page: 1654 issue: 12 year: 2017 end-page: 1662 article-title: Comparison of breast cancer molecular features and survival by African and European ancestry in the Cancer Genome Atlas publication-title: JAMA Oncol – volume: 331 start-page: 233 issue: 3 year: 2024 end-page: 241 article-title: Analysis of breast cancer mortality in the US—1975 to 2019 publication-title: JAMA – volume: 10 year: 2020 article-title: Progress and future trends in PET/CT and PET/MRI molecular imaging approaches for breast cancer publication-title: Front Oncol – volume: 78 start-page: 6011 issue: 20 year: 2018 end-page: 6021 article-title: Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype publication-title: Cancer Res – volume: 4 issue: 2 year: 2021 article-title: Comparative access to and use of digital breast tomosynthesis screening by women's race/ethnicity and socioeconomic status publication-title: JAMA Netw Open – volume: 58 start-page: 71 year: 2019 end-page: 76 article-title: The high and heterogeneous burden of breast cancer in Hawaii: a unique multiethnic U.S. population publication-title: Cancer Epidemiol – volume: 389 start-page: 1453 issue: 10077 year: 2017 end-page: 1463 article-title: Structural racism and health inequities in the USA: evidence and interventions publication-title: Lancet – volume: 142 start-page: 2273 issue: 11 year: 2018 end-page: 2285 article-title: Reproductive history, breast‐feeding and risk of triple negative breast cancer: the Breast Cancer Etiology in Minorities (BEM) study publication-title: Int J Cancer – volume: 113 start-page: 1036 issue: 8 year: 2021 end-page: 1043 article-title: Breast tumor microenvironment in Black women: a distinct signature of CD8+ T‐cell exhaustion publication-title: JNCI: J Natl Cancer Inst – year: 2022 – volume: 180 start-page: 437 issue: 2 year: 2020 end-page: 447 article-title: Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women publication-title: Breast Cancer Res Treat – volume: 12 start-page: 11760 issue: 10 year: 2023 end-page: 11772 article-title: Neighborhood factors and triple negative breast cancer: the role of cumulative exposure to area‐level risk factors publication-title: Cancer Med – volume: 70 start-page: 1 issue: 12 year: 2021 end-page: 27 article-title: Mortality profile of the Non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep – year: 2024 article-title: Risk factors for breast cancer subtypes by race and ethnicity: a scoping review publication-title: J Natl Cancer Inst – volume: 280 start-page: 136 issue: 1 year: 2023 end-page: 143 article-title: Association of Medicaid expansion with reduction in racial disparities in the timely delivery of up‐front surgical care for patients with early‐stage breast cancer publication-title: Ann Surg – volume: 127 start-page: 2545 issue: 14 year: 2021 end-page: 2552 article-title: Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: an analysis of the ECOG‐ACRIN TAILORx trial publication-title: Cancer – volume: 73 start-page: 120 issue: 2 year: 2023 end-page: 146 article-title: Cancer statistics for American Indian and Alaska Native individuals, 2022: including increasing disparities in early onset colorectal cancer publication-title: CA Cancer J Clin – volume: 30 start-page: 623 issue: 4 year: 2021 end-page: 642 article-title: Breast cancer risk factors and survival by tumor subtype: pooled analyses from the Breast Cancer Association Consortium publication-title: Cancer Epidemiol Biomarkers Prev – volume: 331 issue: 22 year: 2024 article-title: Screening for breast cancer: US Preventive Services Task Force recommendation statement publication-title: JAMA – volume: 115 start-page: 139 issue: 2 year: 2023 end-page: 145 article-title: Breast cancer screening during the COVID‐19 pandemic: moving from disparities to health equity publication-title: J Natl Cancer Inst – volume: 19 start-page: 1208 issue: 5 year: 2010 end-page: 1218 article-title: Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave publication-title: Cancer Epidemiol Biomarkers Prev – volume: 2014 start-page: 210 issue: 49 year: 2014 end-page: 217 article-title: The impact of follow‐up type and missed deaths on population‐based cancer survival studies for Hispanics and Asians publication-title: J Natl Cancer Inst Monogr – volume: 10 year: 2020 article-title: The contribution of race to breast tumor microenvironment composition and disease progression publication-title: Front Oncol – volume: 36 start-page: 14 issue: 1 year: 2018 end-page: 24 article-title: Factors that contributed to Black–White disparities in survival among nonelderly women with breast cancer between 2004 and 2013 publication-title: J Clin Oncol – volume: 115 start-page: 644 issue: 6 year: 2023 end-page: 651 article-title: Medicaid expansion, chemotherapy delays, and racial disparities among women with early‐stage breast cancer publication-title: J Natl Cancer Inst – volume: 115 start-page: 1109 issue: 9 year: 2023 end-page: 1111 article-title: Interpreting cancer incidence trends: challenges due to the COVID‐19 pandemic publication-title: J Natl Cancer Inst – volume: 270 start-page: 484 issue: 3 year: 2019 end-page: 492 article-title: Hereditary susceptibility for triple negative breast cancer associated with Western Sub‐Saharan African ancestry: results from an international surgical breast cancer collaborative publication-title: Ann Surg – volume: 28 start-page: 59 issue: 1 year: 2019 end-page: 66 article-title: Multilevel examination of health disparity: the role of policy implementation in neighborhood context, in patient resources, and in healthcare facilities on later stage of breast cancer diagnosis publication-title: Cancer Epidemiol Biomarkers Prev – volume: 103 start-page: 1397 issue: 18 year: 2011 end-page: 1402 article-title: Incidence of breast cancer in the United States: current and future trends publication-title: J Natl Cancer Inst – volume: 314 start-page: 1599 issue: 15 year: 2015 end-page: 1614 article-title: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society publication-title: JAMA – volume: 6 issue: 11 year: 2023 article-title: Racial and ethnic disparity in preoperative chemosensitivity and survival in patients with early‐stage breast cancer publication-title: JAMA Netw Open – volume: 16 year: 2019 article-title: Higher breast cancer risk among immigrant Asian American women than among US‐Born Asian American women publication-title: Prev Chronic Dis – volume: 125 start-page: 3401 issue: 19 year: 2019 end-page: 3411 article-title: Breast cancer subtypes among Eastern‐African–born Black women and other Black women in the United States publication-title: Cancer – volume: 97 start-page: 135 issue: 2 year: 2006 end-page: 144 article-title: The natural history of ductal carcinoma in situ of the breast: a review publication-title: Breast Cancer Res Treat – start-page: P60 year: 2023 end-page: P281 – volume: 178 start-page: 433 issue: 2 year: 2019 end-page: 440 article-title: Differences in breast cancer outcomes amongst Black US‐born and Caribbean‐born immigrants publication-title: Breast Cancer Res Treat – volume: 356 start-page: 1670 issue: 16 year: 2007 end-page: 1674 article-title: The decrease in breast‐cancer incidence in 2003 in the United States publication-title: N Engl J Med – volume: 8 start-page: 863 issue: 6 year: 2022 end-page: 870 article-title: Association of Medicaid expansion with mortality disparity by race and ethnicity among patients with de novo stage IV breast cancer publication-title: JAMA Oncol – volume: 113 start-page: 390 issue: 4 year: 2021 end-page: 399 article-title: Race, ethnicity, and clinical outcomes in hormone receptor‐positive, HER2‐negative, node‐negative breast cancer in the randomized TAILORx trial publication-title: J Natl Cancer Inst – volume: 128 start-page: 2728 issue: 14 year: 2022 end-page: 2735 article-title: Racial disparity in distant recurrence‐free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials publication-title: Cancer – volume: 58 start-page: 9 issue: 1 year: 2008 end-page: 31 article-title: Association of insurance with cancer care utilization and outcomes publication-title: CA Cancer J Clin – volume: 41 start-page: 4352 issue: 27 year: 2023 end-page: 4359 article-title: Cancer screening in the United States during the second year of the COVID‐19 pandemic publication-title: J Clin Oncol – volume: 114 start-page: 1476 issue: 11 year: 2022 end-page: 1483 article-title: Estimation of the number of individuals living with metastatic cancer in the United States publication-title: J Natl Cancer Inst – volume: 386 start-page: 2349 issue: 25 year: 2022 end-page: 2352 article-title: The emergence of the racial disparity in U.S. breast‐cancer mortality publication-title: N Engl J Med – year: 2012 – volume: 26 start-page: 692 issue: 5 year: 2017 end-page: 701 article-title: The interaction between genetic ancestry and breast cancer risk factors among Hispanic women: the Breast Cancer Health Disparities study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 128 start-page: 1024 issue: 5 year: 2022 end-page: 1037 article-title: Disease characteristics and mortality among Asian women with breast cancer publication-title: Cancer – volume: 53 start-page: 872 issue: 10 year: 2015 end-page: 878 article-title: Racial/ethnic disparities in time to a breast cancer diagnosis: the mediating effects of health care facility factors publication-title: Med Care – volume: 35 start-page: 903 issue: 4 year: 2006 end-page: 919 article-title: Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause‐specific mortality of native‐born and foreign‐born populations in the United States, 1979–2003 publication-title: Int J Epidemiol – volume: 74 start-page: 12 issue: 1 year: 2024 end-page: 49 article-title: Cancer statistics, 2024 publication-title: CA Cancer J Clin – volume: 30 start-page: 344 issue: 2 year: 2021 end-page: 350 article-title: Neighborhood social environmental factors and breast cancer subtypes among Black women publication-title: Cancer Epidemiol Biomarkers Prev – volume: 164 start-page: 139 issue: 1 year: 2017 end-page: 147 article-title: Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes publication-title: Breast Cancer Res Treat – volume: 99 start-page: 1044 issue: 13 year: 2007 end-page: 1049 article-title: Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement publication-title: J Natl Cancer Inst – volume: 381 year: 2023 article-title: Advances in systemic therapies for triple negative breast cancer publication-title: BMJ – year: 2020 – year: 2023 – volume: 25 start-page: 259 issue: 2 year: 2014 end-page: 265 article-title: Parity and breastfeeding among African‐American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health study publication-title: Cancer Causes Control – volume: 2 start-page: 322 issue: 3 year: 2016 end-page: 329 article-title: Delayed initiation of adjuvant chemotherapy among patients with breast cancer publication-title: JAMA Oncol – volume: 72 start-page: 542 issue: 6 year: 2022 end-page: 560 article-title: Health insurance status and cancer stage at diagnosis and survival in the United States publication-title: CA Cancer J Clin – volume: 12 start-page: 2530 issue: 11 year: 2022 end-page: 2551 article-title: African Ancestry‐associated gene expression profiles in triple‐negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent publication-title: Cancer Discov – volume: 21 start-page: 83 issue: 1 year: 2010 end-page: 90 article-title: The impact of changes in hormone therapy on breast cancer incidence in the US population publication-title: Cancer Causes Control – volume: 230 start-page: 775 issue: 5 year: 2020 end-page: 783 article-title: Affordable Care Act state‐specific Medicaid expansion: impact on health insurance coverage and breast cancer screening rate publication-title: J Am Coll Surg – volume: 159 start-page: 712 issue: 6 year: 2024 end-page: 714 article-title: Tumor‐associated lymphocytes and breast cancer survival in Black and White Women publication-title: JAMA Surg – volume: 10 start-page: 6456 issue: 18 year: 2021 end-page: 6467 article-title: Relationship of established risk factors with breast cancer subtypes publication-title: Cancer Med – volume: 67 start-page: 93 issue: 2 year: 2017 end-page: 99 article-title: The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging publication-title: CA Cancer J Clin – volume: 27 start-page: 1214 issue: 10 year: 2018 end-page: 1222 article-title: Proportion of U.S. trends in breast cancer incidence attributable to long‐term changes in risk factor distributions publication-title: Cancer Epidemiol Biomarkers Prev – ident: e_1_2_7_95_1 doi: 10.1093/ije/dyl089 – ident: e_1_2_7_94_1 doi: 10.1007/s11113‐021‐09647‐6 – ident: e_1_2_7_44_1 doi: 10.1093/jncimonographs/lgu016 – ident: e_1_2_7_68_1 doi: 10.1056/nejmp2200244 – ident: e_1_2_7_29_1 doi: 10.1158/1055‐9965.epi‐10‐0021 – ident: e_1_2_7_59_1 doi: 10.1093/jnci/djv159 – ident: e_1_2_7_28_1 doi: 10.1016/j.canep.2018.11.006 – ident: e_1_2_7_33_1 doi: 10.1093/jnci/djae172 – ident: e_1_2_7_24_1 doi: 10.1002/cncr.32293 – ident: e_1_2_7_69_1 doi: 10.1093/jnci/djaa148 – ident: e_1_2_7_89_1 doi: 10.1016/j.clinimag.2021.08.013 – ident: e_1_2_7_11_1 – volume-title: 2021 BRFSS Survey Data and Documentation year: 2023 ident: e_1_2_7_14_1 – ident: e_1_2_7_47_1 doi: 10.1136/bmj‐2022‐071674 – ident: e_1_2_7_70_1 doi: 10.1158/1538‐7445.sabcs22‐gs1‐01 – ident: e_1_2_7_25_1 doi: 10.1007/s10549‐017‐4229‐1 – ident: e_1_2_7_66_1 doi: 10.3389/fonc.2020.01301 – ident: e_1_2_7_86_1 doi: 10.1093/jnci/djaa215 – ident: e_1_2_7_90_1 doi: 10.1093/jnci/djaa215 – ident: e_1_2_7_39_1 doi: 10.1007/s10552‐013‐0323‐9 – ident: e_1_2_7_60_1 doi: 10.15620/cdc/151797 – ident: e_1_2_7_55_1 doi: 10.1007/s10552‐009‐9437‐5 – ident: e_1_2_7_84_1 doi: 10.1002/cncr.33527 – volume-title: DevCan: Probability of Developing or Dying of Cancer Software. Version 6.7.5 year: 2012 ident: e_1_2_7_18_1 – ident: e_1_2_7_93_1 doi: 10.1016/j.jamcollsurg.2020.01.031 – ident: e_1_2_7_8_1 – ident: e_1_2_7_5_1 – ident: e_1_2_7_50_1 doi: 10.1200/jco.23.01199 – ident: e_1_2_7_10_1 – ident: e_1_2_7_78_1 doi: 10.1200/jco.2017.73.7932 – ident: e_1_2_7_87_1 doi: 10.3389/fonc.2020.01022 – ident: e_1_2_7_92_1 doi: 10.1158/2159‐8290.cd‐22‐0138 – ident: e_1_2_7_91_1 doi: 10.1001/jamasurg.2023.8024 – ident: e_1_2_7_30_1 – ident: e_1_2_7_37_1 doi: 10.1097/sla.0000000000003459 – ident: e_1_2_7_82_1 doi: 10.1001/jamaoncol.2021.1254 – start-page: P60 volume-title: US Census Bureau, Current Population Reports, P60‐821, Health Insurance Coverage in the United States: 2022 year: 2023 ident: e_1_2_7_75_1 – volume-title: SEER*Stat software. Version 8.4.3 year: 2024 ident: e_1_2_7_16_1 – ident: e_1_2_7_96_1 doi: 10.3322/caac.21757 – ident: e_1_2_7_49_1 doi: 10.1001/jamaoncol.2021.1254 – volume-title: National Health Interview Survey: 2021 NHIS year: 2022 ident: e_1_2_7_13_1 – ident: e_1_2_7_27_1 doi: 10.3390/ijerph182211824 – ident: e_1_2_7_48_1 doi: 10.1200/jop.2017.023333 – ident: e_1_2_7_38_1 doi: 10.1002/ijc.31258 – ident: e_1_2_7_34_1 doi: 10.1093/jnci/djv048 – ident: e_1_2_7_62_1 doi: 10.5888/pcd16.180221 – ident: e_1_2_7_36_1 doi: 10.1001/jamaoncol.2017.0595 – ident: e_1_2_7_58_1 doi: 10.1093/jnci/djab186 – ident: e_1_2_7_15_1 doi: 10.3322/caac.21820 – ident: e_1_2_7_41_1 doi: 10.1158/1055‐9965.epi‐20‐1055 – ident: e_1_2_7_88_1 doi: 10.1002/cncr.34241 – ident: e_1_2_7_76_1 doi: 10.3322/ca.2007.0011 – ident: e_1_2_7_56_1 doi: 10.1056/nejmsr070105 – ident: e_1_2_7_26_1 doi: 10.1002/cncr.34015 – ident: e_1_2_7_42_1 doi: 10.1093/jncics/pkac016 – ident: e_1_2_7_72_1 doi: 10.1158/1055‐9965.epi‐17‐0945 – volume-title: Cancer Prevention & Early Detection Facts & Figures 2023–2024 year: 2023 ident: e_1_2_7_52_1 – ident: e_1_2_7_63_1 doi: 10.1001/jama.2024.5535 – ident: e_1_2_7_22_1 – ident: e_1_2_7_57_1 doi: 10.1158/1055‐9965.epi‐18‐0098 – ident: e_1_2_7_77_1 doi: 10.3322/caac.21732 – ident: e_1_2_7_79_1 doi: 10.1093/jnci/djad033 – ident: e_1_2_7_19_1 doi: 10.1093/jnci/djad086 – ident: e_1_2_7_32_1 doi: 10.1002/cam4.4158 – ident: e_1_2_7_46_1 doi: 10.1007/s10549‐019‐05403‐9 – ident: e_1_2_7_21_1 doi: 10.1093/jnci/djr257 – volume-title: Cancer Facts & Figures for Asian American, Native Hawaiian, and Other Pacific Islander People 2024–2026 year: 2024 ident: e_1_2_7_45_1 – ident: e_1_2_7_31_1 doi: 10.1158/0008‐5472.can‐18‐0502 – ident: e_1_2_7_7_1 – ident: e_1_2_7_74_1 doi: 10.1001/jamanetworkopen.2020.37546 – ident: e_1_2_7_40_1 doi: 10.1007/s10549‐020‐05545‐1 – ident: e_1_2_7_51_1 doi: 10.1097/00008469‐199311000‐00001 – ident: e_1_2_7_85_1 doi: 10.1001/jamanetworkopen.2023.44517 – ident: e_1_2_7_80_1 doi: 10.1001/jamaoncol.2022.0159 – ident: e_1_2_7_2_1 doi: 10.1001/jamaoncol.2022.2617 – ident: e_1_2_7_83_1 doi: 10.1001/jamaoncol.2015.3856 – ident: e_1_2_7_65_1 doi: 10.1093/jnci/djm026 – ident: e_1_2_7_61_1 doi: 10.1158/1055‐9965.epi‐20‐0924 – ident: e_1_2_7_71_1 doi: 10.1016/s0140‐6736(17)30569‐x – volume-title: Joinpoint Regression Program. Version 5.2.0.0 year: 2024 ident: e_1_2_7_17_1 – ident: e_1_2_7_81_1 doi: 10.1097/sla.0000000000006177 – ident: e_1_2_7_53_1 doi: 10.1007/s10549‐005‐9101‐z – ident: e_1_2_7_4_1 doi: 10.1093/jnci/djac172 – ident: e_1_2_7_6_1 – volume: 70 start-page: 1 issue: 12 year: 2021 ident: e_1_2_7_20_1 article-title: Mortality profile of the Non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep – ident: e_1_2_7_35_1 doi: 10.1158/1055‐9965.epi‐16‐0721 – ident: e_1_2_7_73_1 doi: 10.1097/mlr.0000000000000417 – ident: e_1_2_7_54_1 doi: 10.3322/caac.21388 – ident: e_1_2_7_23_1 doi: 10.1093/jnci/djac158 – ident: e_1_2_7_9_1 – ident: e_1_2_7_43_1 doi: 10.1002/cam4.5808 – ident: e_1_2_7_64_1 doi: 10.1001/jama.2015.12783 – ident: e_1_2_7_12_1 – ident: e_1_2_7_3_1 doi: 10.1200/jco.22.02170 – ident: e_1_2_7_67_1 doi: 10.1001/jama.2023.25881 |
| SSID | ssj0000777 |
| Score | 2.7484365 |
| Snippet | This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high‐quality incidence and mortality data from the... This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 477 |
| SubjectTerms | Adult Age Distribution Aged Aged, 80 and over American Cancer Society Asian Americans Black people Breast cancer breast neoplasms Breast Neoplasms - epidemiology Breast Neoplasms - ethnology Breast Neoplasms - mortality epidemiology Female health disparities Humans Incidence Middle Aged molecular subtype Mortality Pacific Islander people SEER Program - statistics & numerical data Social determinants of health Statistics United States - epidemiology White people Womens health Young Adult |
| Title | Breast cancer statistics 2024 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21863 https://www.ncbi.nlm.nih.gov/pubmed/39352042 https://www.proquest.com/docview/3130875666 https://www.proquest.com/docview/3111637498 |
| Volume | 74 |
| WOSCitedRecordID | wos001322701200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: 24P dateStart: 19970101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED90ivji90f9oqIvCsWmTZYGfJlDUdCxBz_2VpK0eZJN5ubf713abYgiiC-l0Avp5S65X5re7wBOdcmEk1pFFL8ibihZuSlMVJi4NLrpDPO1CJ7vZaeT9XqqOweXk1yYih9i-sGNZoZfr2mCa-OrkKTog2hEq7FDqqiUzsMCY2lGhRsS3p2tw1JWjJmxjBDGiIqclFpfzNp-DUffMOZXyOpjzs3q_952DVZqrBm2KudYh7myvwFLD_Vp-iYcXtEf6aPQkuWHIeUWVbTNYYIxdQuebq4f27dRXS4hslyoFHeCTCcua8qYa8mdJ1pJjYydFVIZDFZOITizqsRNUoESwjqRGCmKhOtMxTrdhkZ_0C93ISwcQyAkNHdKcM2EwSYabWqTpMhUyQM4m4xabmsucSpp8ZrjnoI0zknf3OsbwMlU9q1i0PhR6mAy-Hk9i97zlBFfIQLOZgDH08fo_3SoofvlYEwyDNWUXGUB7FRGm3ZDaccJrkoBnHvb_NJ_3m612v5u7y_C-7BMFqmSEw-gMRqOy0NYtB9or-GR90e8yl6G15e7zielZN6a |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZ4CbjwfhQGFMEFpIo-kqU5jolpE9vEYcBuVZI2J9ShsfH7sduyCYGQELdKdZQ6juMvSf0Z4FJlAbdCSY_il8c0JSvXufZS7Wda1a0OiloET13R78fDoXyo_s2hXJiSH2J24EaeUazX5OB0IE1eHuEkRCsahT1SSaVoEZYZIg2q3PDc6c8XYiFKykxfeIhjeMlOSq1v5m2_xqNvIPMrZi2CTmvzn5-7BRsV2nQb5fTYhoUs34HVXnWfvgsnt_RP-sQ1ZPuxS9lFJXGzG2JU3YPH1t2g2faqggmeYVxGuBcMVGjjuvCZEswWVCuRFr41XEiN4cpKhGdGZrhNSlGCG8tDLXgaMhVLX0X7sJSP8uwQ3NQGCIW4YlZypgKusYlCq5owTGOZMQeuPoctMRWbOBW1eElwV0EaJ6RvUujrwMVM9rXk0PhRqvY5-knlR29JFBBjIULOugPns9foAXStofJsNCWZANUUTMYOHJRWm3VDicchrksOXBfG-aX_pNloNIuno78In8Fae9DrJt1O__4Y1sk6ZapiDZYm42l2AivmHW03Pi0m5wcTQeD7 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZgIMSF96M8i-ACUkUfSdMcx2ACAdMOgLhVSZqcUIfG4Pdjt90mBEJC3CrVVurYjp0m_gxwomzEnVAyoPgVME3FyinXQaFDq1XqdFT1Ini6E71e9vws-83dHKqFqfEhJj_cyDOq9Zoc3L4Wjrw8QSNELRqFI1JLpWQW5hgXERl1zPrThViIGjIzFAHmMbxGJyXu8ynv13j0Lcn8mrNWQae7_M_PXYGlJtv027V5rMKMLddg4b45T1-H_Qu6kz7yDel-6FN1UQ3c7McYVTfgsXv10LkOmoYJgWFcJrgXjFTsslSETAnmKqiVRIvQGS6kxnDlJKZnRlrcJhVIwY3jsRa8iJnKZKiSTWiVg9Jug1-4CFMhrpiTnKmIa2RRqFUTx0UmLfPgdDxtuWnQxKmpxUuOuwqSOCd580peD44ntK81hsaPVHvj2c8bP3rLk4gQCzHlTD04mrxGD6BjDVXawTvRRCimYDLzYKvW2mQYKjyOcV3y4KxSzi_j5512u1M97fyF-BAW-pfd_O6md7sLi6SculJxD1qj4bvdh3nzgaobHlS2-QlWMOAS |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+statistics+2024&rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&rft.au=Giaquinto%2C+Angela+N&rft.au=Sung%2C+Hyuna&rft.au=Newman%2C+Lisa+A&rft.au=Freedman%2C+Rachel+A&rft.date=2024-11-01&rft.issn=1542-4863&rft.eissn=1542-4863&rft.volume=74&rft.issue=6&rft.spage=477&rft_id=info:doi/10.3322%2Fcaac.21863&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-9235&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-9235&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-9235&client=summon |